Table 1.
Descriptive Characteristics of Study Sample
| Full sample N=242 n (%) | MSM N=69 n (%) | MSW N=68 n (%) | WSM N=105 n (%) | ANOVA or χ2 | |
|---|---|---|---|---|---|
| Serostatus disclosure | 211 (88.7) | 56 (81.2) | 62 (92.5) | 93 (91.2) | χ2 (2)=5.50 |
| Demographic characteristics | |||||
| Age [M (SD)] | 42.7 (8.9) | 39.9 (9.6)a | 44.5 (8.5)b | 43.3 (8.2)b | F (2,239)=5.47** |
| Race | |||||
| African American/black | 172 (71.1) | 40 (58.0)a | 53 (77.9)b | 79 (75.2) | χ2 (2)=8.21* |
| Caucasian/white | 47 (19.4) | 21 (30.4) | 8 (11.8) | 18 (17.2) | |
| Other | 23 (9.5) | 8 (11.6) | 7 (10.3) | 8 (7.6) | |
| Education | |||||
| High school or less | 140 (57.9) | 18 (26.1)a | 52 (76.5)b | 70 (66.7)b | χ2 (2)=41.57*** |
| Some college or more | 102 (42.1) | 51 (73.9) | 16 (23.5) | 35 (33.3) | |
| Employment | |||||
| Not employed | 151 (62.4) | 36 (52.2) | 46 (67.6) | 69(65.7) | χ2 (2)=4.53 |
| Full or part-time | 91 (37.6) | 33 (47.8) | 22 (32.4) | 36 (34.3) | |
| Clinical characteristics | |||||
| Currently on ART | 205 (84.7) | 63 (91.3) | 62 (91.2) | 80 (76.2) | χ2 (2)=5.96 |
| Undetectable viral load | 133 (54.9) | 40 (57.9) | 38 (55.1) | 55 (52.4) | χ2 (2)=0.53 |
| Years since diagnosis [M (SD)] | 9.5 (5.7) | 8.3 (5.7) | 10.4 (5.8) | 9.6 (5.6) | F (2,235)=2.32 |
| Substance use characteristics | |||||
| Alcohol use | 128 (53.1) | 47 (68.1)a | 42 (61.8)a | 39 (37.5)b | χ2 (2)=13.51** |
| Marijuana use | 42 (17.9) | 10 (14.5) | 17 (25.8) | 15 (14.3) | χ2 (2)=3.89 |
| Crack use | 32 (13.6) | 5 (7.3) | 10 (15.2) | 17 (16.2) | χ2 (2)=3.49 |
| Partner serostatus | |||||
| HIV-positive | 85 (35.1) | 25 (36.2) | 29 (42.7) | 31 (29.5) | χ2 (2)=3.17 |
| HIV-negative | 119 (49.2) | 29 (42.0) | 32 (47.1) | 58 (55.2) | χ2 (2)=3.07 |
| Unknown | 38 (15.7) | 15 (21.7) | 7 (10.3) | 16 (15.2) | χ2 (2)=3.42 |
MSM, men who have sex with men. ANOVAs were used to test group differences on continuous variables; χ2 tests were used to test group differences in dichotomous variables. Different superscripts within a row (a,b) indicate significant differences (p<0.05) between groups with Bonferroni-adjusted post-hoc tests. *p<0.05, **p<0.01, ***p<0.001.